Article Details

Research Pinpoints Weakness in Lung Cancer's Defenses | Harvard Medical School

Retrieved on: 2025-02-07 16:37:24

Tags for this article:

Click the tags to see associated articles and topics

Research Pinpoints Weakness in Lung Cancer's Defenses | Harvard Medical School. View article details on hiswai:

Summary

The article discusses a cancer research funded by multiple organizations, involving authors linked to various biopharma companies—such as AstraZeneca, Pfizer, and Roche—highlighting the strong US presence in biopharma research and development.

Article found on: hms.harvard.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up